司美格鲁肽与肥胖及多囊卵巢综合征女性的味觉:一项随机安慰剂对照研究
这项16周单盲安慰剂对照研究纳入30例肥胖合并多囊卵巢综合征(PCOS)女性,随机接受司美格鲁肽1.0 mg每周一次或安慰剂。司美格鲁肽使总体味觉识别评分从11.9±1.9分提高至14.4±1.0分,估计治疗差异为2.5分(95%CI 1.7-3.3),并改变舌组织RNA表达及脑对食物线索的反应。
要点
- 司美格鲁肽使总体味觉识别评分提高,估计治疗差异2.5分(95%CI 1.7-3.3)。
- EYA、PRMT8、CRLF1、CYP1B1等味觉信号与味蕾更新相关基因RNA表达出现差异。
- 司美格鲁肽降低对视觉食物线索的壳核激活,增加餐后甜溶液引发的角回活动(P<.001)。
核心结论
- 在肥胖合并PCOS女性中,司美格鲁肽改善了总体味觉识别评分,改变了舌组织RNA表达,并改变了对甜咸食物线索及品尝甜溶液的大脑活动。
研究设计与样本
- 16周单盲安慰剂对照研究,纳入30例年龄33.7±6.1岁、体重指数36.4±4.4 kg/m2的PCOS女性,随机接受司美格鲁肽1.0 mg每周一次或安慰剂。
- 味觉识别变化用16条浸渍4种基本味觉各4个浓度的试纸评估,并行舌活检做基因表达分析,用功能磁共振成像评估大脑对甜咸食物视觉线索及甜溶液滴舌的反应。
主要发现
- 司美格鲁肽使总体味觉识别评分从11.9±1.9分提高至14.4±1.0分,估计治疗差异为2.5分(95%CI 1.7-3.3)。
- 与味觉信号转导通路、神经可塑性及味蕾更新相关的基因EYA、PRMT8、CRLF1、CYP1B1经多层级分析流程显示RNA表达差异。
- 司美格鲁肽降低了对视觉食物线索的壳核激活,并增加了餐后甜溶液引发的顶叶皮层角回活动(司美格鲁肽 vs 安慰剂,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Relationship between obesity and the sense of taste is complex, with many inconsistent and conflicting findings that are largely methodology dependent. The impact of glucagon-like peptide-1 analogues on taste remains largely unaddressed. METHODS: In this 16-week, single-blinded, placebo-controlled study, 30 women with polycystic ovary syndrome (PCOS), aged 33.7 ± 6.1 years with a body mass index of 36.4 ± 4.4 kg/m2 were randomized to semaglutide 1.0 mg once weekly or placebo. Change in taste recognition was assessed by 16 strips impregnated with 4 different concentrations of the 4 basic tastes. Tongue biopsies were performed for gene expression analysis. Brain responses to visual cues of sweet and savory foods and to sweet solution dripping on the tongue were evaluated by functional magnetic resonance imaging. RESULTS: Semaglutide improved overall taste recognition score from 11.9 ± 1.9 points to 14.4 ± 1.0 points, with an estimated treatment difference of 2.5 points (95% CI, 1.7-3.3). The genes EYA, PRMT8, CRLF1, and CYP1B1, which are associated with taste signaling transduction pathways, neural plasticity, and renewal of taste buds, showed differential RNA expression by a multi-tiered analytical pipeline. Semaglutide decreased activation of putamen in response to visual food cues and increased activity in the angular gyrus of the parietal cortex in response to sweet solution after meal intake (semaglutide vs placebo, P < .001). CONCLUSION: In women with obesity and PCOS, semaglutide improved an overall taste recognition score, altered RNA expression in the tongue and modified brain activity in response to sweet and savory food cues and to tasting sweet solution.
引用
- Jensterle M, Kovac J, Vovk A, et al. Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study. J Clin Endocrinol Metab. 2025. PMID: 40341357. doi:10.1210/clinem/dgaf278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。